Local and intralesional therapy of in-transit melanoma metastases. - Wikidata - wikimedia - TriplyDB

Local and intralesional therapy of in-transit melanoma metastases.

Local and intralesional therapy of in-transit melanoma metastases.

http://www.wikidata.org/entity/Q37920837

about

sameAs

Electrochemotherapy: from the drawing board into medical practice Developments in Intralesional Therapy for Metastatic Melanoma Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacological data in 34 patients.Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.Current treatment of locoregional recurrence of melanoma.Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma.Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.Isolated limb infusion in a series of over 100 infusions: a single-center experience.The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma Treatment of in-transit melanoma with intralesional bacillus Calmette-Guérin (BCG) and topical imiquimod 5% cream: a report of 3 cases.Effectiveness of electrochemotherapy after IFN-α adjuvant therapy of melanoma patients Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit.Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.Melphalan: a promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Intralesional immunotherapy for melanoma.Intralesional therapy with PV-10 (Rose Bengal) for in-transit melanoma.Treatment of metastatic melanoma with electrochemotherapy.Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy.Intralesional therapy for metastatic melanoma.Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy.Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study.Tumor size and effectiveness of electrochemotherapy.Australian Multicenter Study of Isolated Limb Infusion for Melanoma.Results of a phase II, open-label, non-comparative study of intralesional PV-10 followed by radiotherapy for the treatment of in-transit or metastatic melanoma.Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study.Intraoperative electrochemotherapy of colorectal liver metastases.Randomized phase III trial of adjuvant therapy with locoregional interferon beta versus surgery alone in stage II/III cutaneous melanoma: Japan Clinical Oncology Group Study (JCOG1309, J-FERON).Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases of the skin; the 5-year Norwich experience.Subcutaneous metastases from melanoma: a discussion of clinical experience Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease

P2860

Q26863455-00070718-6D33-417B-821F-A129BC9D0B93 Q26863455-998B75BC-10E0-4A5A-9FFF-D974B9519735 Q28069615-54154140-31C6-4C02-B8F3-1C3DC27C3374 Q28069615-DBA3AC1B-D6A9-46DA-8596-EB1A8A01297E Q34343492-804C1C79-B400-4729-B321-9756D9E2C4B2 Q34613089-A518AA5A-6831-41EB-A2A7-21E4FE0DAA5A Q34888462-4106A486-66BD-4011-96E8-B53B4CEA7DCB Q35690688-39A66DDC-E564-4A2D-8D77-317A84392618 Q35690688-794D5337-48F7-4597-8A20-AD3A137CED6D Q35857551-2B1AD4C2-7472-4C0C-96F1-AE2BE3CD09F2 Q35857551-37FC7D52-D3D5-4805-90B0-80ACE7B6F534 Q35857556-24232702-001B-4170-9A81-2AD84F25CBAA Q35857556-BFCD9C22-87D4-49C5-8E31-D57A314E6EC5 Q36102807-B3236356-D2E4-4CB2-B184-01ED17E2AF72 Q36102807-F8AD22F4-4DEA-499B-9F0C-E225A75BFED7 Q36112819-1056CA49-65D7-4CA8-A79A-3979026A686C Q36112819-4388FA8A-D8FF-43A7-B683-05E5DA7FA2A1 Q36322376-B856E52A-B7CB-4343-86A9-213B8164BDA0 Q36779843-62C2A97E-0C19-442A-A991-3CCB26B7E086 Q36908347-A6D3FDC3-7322-489A-B37B-8D1B59826141 Q36908347-B14E5729-E449-499A-80D1-ADFE45825649 Q37120289-01AE4342-4651-4B23-86E7-8BC7405BC334 Q37120289-3467CFEA-0DE2-4FB0-82E7-3172B672601B Q38088212-522DE570-899F-42A0-9257-E2486E73EBEA Q38166245-41CCA4AB-C767-42D9-A30C-DD637B9F3969 Q38168460-1C7A784A-4BB1-4F55-ACB7-329D4A14156C Q38186621-47F747BF-D811-406B-8B87-9A726BD67811 Q38200101-C1799D01-4E6F-4407-8893-51A6498742AC Q38200527-E1699104-6AA2-4123-90C8-780C4A0FF45A Q38266193-E6849EB5-8AEB-41ED-B58D-E688A29F9E10 Q38988662-F8A86B79-0CA6-406C-9546-40E5F4ABD206 Q39381921-8DA748E7-9D6E-48F3-BD8C-AFC56C982937 Q39459398-243E6E31-2837-4387-9A30-49993F12DC23 Q40307423-D984DF67-7BCA-4A1F-AFDF-CBB8ABE34CD2 Q40322347-5E555949-4C5C-43B3-A666-F28B1764CC66 Q41740586-F3BACC45-3DC0-49AD-AEB7-BF402A50A98D Q46829602-78B12552-9D7C-4F7F-ABC9-DDD2C0B3A606 Q50025731-4AFB2FF5-788A-4C6C-9E9A-0ECFBF0BADEE Q50025731-B63F852D-6130-4ABE-8282-44EB3F8D55C2 Q50709661-230BEF98-1EF9-4ECA-8745-1A25F3C708A9

P2860

Local and intralesional therapy of in-transit melanoma metastases.

http://www.wikidata.org/entity/Q37920837

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Local and intralesional therapy of in-transit melanoma metastases.

@en

Local and intralesional therapy of in-transit melanoma metastases.

@nl

type

label

Local and intralesional therapy of in-transit melanoma metastases.

@en

Local and intralesional therapy of in-transit melanoma metastases.

@nl

prefLabel

Local and intralesional therapy of in-transit melanoma metastases.

@en

Local and intralesional therapy of in-transit melanoma metastases.

@nl

P1433

Q37920837-E7C9A98A-2188-467C-97EC-3734B7AED042

P1476

Q37920837-AF80B41A-7DDE-4E04-8B60-1E189D394859

P2093

Q37920837-1E723B20-3189-4761-9AB4-5F5306A21788

Q37920837-356046AA-5B2A-4C34-8648-69C114D619EC

Q37920837-3E732AC7-F435-4246-B6DF-B18ED6770EBE

Q37920837-467BD9B3-692B-4261-8AA5-7481DD0B0A1C

Q37920837-49A403B2-22E4-44D6-A6D0-0875F98527D1

Q37920837-61DE6435-299E-4BC0-9785-4AA6BA1F0FFD

Q37920837-639D59DA-07B6-4C24-AD72-D62367906693

Q37920837-984AA832-430C-4A7F-BF84-006C22A2BCFC

Q37920837-BBA0DA2E-BF31-49F4-8357-29BAE461A4A4

P304

Q37920837-04F46A41-356F-4BFD-A0F3-9D275F7171EB

P31

Q37920837-36CB0009-03AF-49F8-BCB6-3702F3AF1097

P356

Q37920837-F495DD87-4C9D-4EDA-A6E1-382A4CA4961C

P433

Q37920837-DE94C9BA-CF28-43BD-9579-78037E2FD2D9

P478

Q37920837-6F6938C6-1454-4186-89EB-2205E465E1E0

P577

Q37920837-7E433B02-E4A2-45F0-817C-C1F8FF2393E5

P698

Q37920837-75C19CD1-A512-4008-A81A-C268097237F6

P356

P1433

Journal of Surgical Oncology

P1476

Local and intralesional therapy of in-transit melanoma metastases.

@en

P2093

Albertus N van Geel

http://www.w3.org/2001/XMLSchema#string

Alessandro Testori

http://www.w3.org/2001/XMLSchema#string

Cornelis Verhoef

http://www.w3.org/2001/XMLSchema#string

E Pennacchioli

http://www.w3.org/2001/XMLSchema#string

Francesco Verrecchia

http://www.w3.org/2001/XMLSchema#string

Jan P Deroose

http://www.w3.org/2001/XMLSchema#string

Javier Soteldo

http://www.w3.org/2001/XMLSchema#string

John F Thompson

http://www.w3.org/2001/XMLSchema#string

Mark B Faries

http://www.w3.org/2001/XMLSchema#string

P304

391-396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.22029

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21858834

http://www.w3.org/2001/XMLSchema#string